Acadia Pharmaceuticals (ACAD) Inventory (2016 - 2025)
Historic Inventory for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Q3 2025 value amounting to $29.1 million.
- Acadia Pharmaceuticals' Inventory fell 5233.2% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year decrease of 5233.2%. This contributed to the annual value of $21.9 million for FY2024, which is 3872.25% down from last year.
- Acadia Pharmaceuticals' Inventory amounted to $29.1 million in Q3 2025, which was down 5233.2% from $26.1 million recorded in Q2 2025.
- Acadia Pharmaceuticals' Inventory's 5-year high stood at $71.5 million during Q2 2024, with a 5-year trough of $5.8 million in Q3 2022.
- Its 5-year average for Inventory is $22.9 million, with a median of $14.3 million in 2021.
- In the last 5 years, Acadia Pharmaceuticals' Inventory soared by 91617.72% in 2024 and then plummeted by 6347.57% in 2025.
- Acadia Pharmaceuticals' Inventory (Quarter) stood at $7.9 million in 2021, then dropped by 15.8% to $6.6 million in 2022, then surged by 439.77% to $35.8 million in 2023, then plummeted by 38.72% to $21.9 million in 2024, then soared by 32.57% to $29.1 million in 2025.
- Its Inventory stands at $29.1 million for Q3 2025, versus $26.1 million for Q2 2025 and $22.9 million for Q1 2025.